LD-2 disclosure · 1st Quarter - Report
ALLERGAN, INC.
via ALLERGAN, INC.
Expenses$530Kself-filed spend
Client
- Name
- ALLERGAN, INC.
- Location
- California · United States of America
Registrant
- Firm
- ALLERGAN, INC.
- Description
- DEVELOP, MANUFACTURE, MARKET AND SELL SPECIALTY PHARMACEUTICALS
- Location
- IRVINE, California, United States of America
Lobbying activities
1 issueHealth Issues
NO SPECIFIC BILL: FOOD AND DRUG ADMINISTRATION (FDA) DRAFT GUIDANCE ON CYCLOSPORINE
Lobbyistsmr EDWARD C RENO iii
Covered position (mr EDWARD C RENO iii): N/A
TargetedSENATE · HOUSE OF REPRESENTATIVES